Operator: Good morning, and welcome to IPA s Earnings Call for the Third Quarter Fiscal Year 2023. I am Regina, and I will be your host for today s call.
IPA’s Project revenue increased by 16.7% compared to the prior year, driven by the growth of the company’s proprietary B cell Select® platform and protein…
The program will leverage BioStrand's LENSai® Full Suite of Integrated Intelligence Technology® with Libera Bio's Multifunctional Polymeric Nanocapsules (MPN Technology®) The Alliance has
The National Foundation for Cancer Research (NFCR) announced winners of the 2021 Salisbury Award Competition for Entrepreneurial Translational Research, selected from among eight semi-finalists after pitch presentations in front of a judging committee consisting of prominent cancer research scientists, clinicians, early-stage investors and business leaders.
Credit: National Foundation for Cancer Research, RadioMedix, TanoMed, Tel Aviv University, Libera Bio
ROCKVILLE, MD - The National Foundation for Cancer Research (NFCR) announced winners of the 2021 Salisbury Award Competition for Entrepreneurial Translational Research, selected from among eight semi-finalists after pitch presentations in front of a judging committee consisting of prominent cancer research scientists, clinicians, early-stage investors and business leaders.
The semi-finalists were determined earlier in the spring based upon applications from among academic laboratories or early-stage companies advancing promising experimental cancer therapeutic, diagnostic, detection and vaccine innovations.
The first prize winner of the Salisbury Award Competition is the cancer therapeutic innovation presented by Ronit Satchi-Fainaro, Ph.D., co-founder and chief scientific officer (CSO) of Israel-based TanoMed, and a professor at Tel Aviv University and director of its Cancer Bio